H You
Overview
Explore the profile of H You including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
812
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lyu T, Duan W, Li S, Chen S, Jia J, You H
Zhonghua Nei Ke Za Zhi
. 2025 Mar;
64(3):255-260.
PMID: 40050096
No abstract available.
2.
Chen S, Meng T, Duan W, Li S, Lyu T, Wang Y, et al.
Zhonghua Nei Ke Za Zhi
. 2025 Mar;
64(3):206-211.
PMID: 40050087
Primary sclerosing cholangitis (PSC) is a rare autoimmune disease. This study aims to describe the baseline characteristics and clinical outcomes of Chinese PSC patients and explore risk factors associated with...
3.
Deng Y, Meng T, You H, Wang Y, Jia J
Zhonghua Gan Zang Bing Za Zhi
. 2025 Mar;
33(2):115-120.
PMID: 40044428
China has made remarkable achievements during the past three decades in controlling chronic hepatitis B virus infection. The overall HBsAg positivity rate dropped from 9.72% in 1992 to 5.86% in...
4.
Chen S, Shan S, Kong Y, Xu X, Wang H, Wu X, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2025 Feb;
33(1):34-40.
PMID: 39929682
To explore the distribution characteristics of HBsAg levels in treatment-naïve and treatment-experienced patients with chronic hepatitis B (CHB) in China. Data were obtained from the China Registry of Hepatitis B...
5.
Zhang L, Liu X, Hu X, Wang J, Yu X, Li G, et al.
Nan Fang Yi Ke Da Xue Xue Bao
. 2024 Nov;
44(9):1831-1838.
PMID: 39505352
Objective: To evaluate the efficacy and safety of transcatheter arterial chemoembolization (TACE) followed by hepatic arterial infusion chemotherapy (HAIC) combined with TKI drugs and PD-1 inhibitors as the first-line treatment...
6.
Wang B, Shan S, Kong Y, Wu X, Zhou J, Sun Y, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2024 Jul;
32(6):525-531.
PMID: 38964895
This study aims to compare the antiviral treatment similarities and differences in the population covered by the 2024 version of the World Health Organization's (WHO) hepatitis B prevention and treatment...
7.
Ai X, Zhang M, Sun Y, You H
Zhonghua Gan Zang Bing Za Zhi
. 2024 Jun;
32(5):385-388.
PMID: 38858185
The global chronic hepatitis B (CHB) guidelines have gradually expanded treatment indications in order to accelerate the elimination and improve the treatment rate of hepatitis B virus (HBV) infection. This...
8.
Li S, You H, Wu Y
Zhonghua Xin Xue Guan Bing Za Zhi
. 2024 Jan;
52(1):103-106.
PMID: 38220465
No abstract available.
9.
Hu G, Yu Y, Yin S, Yang X, Xu Q, You H
Eur Rev Med Pharmacol Sci
. 2023 Sep;
27(16):7544-7556.
PMID: 37667931
Objective: The purpose of this study is to evaluate the combination of iguratimod (IGU) and methylprednisolone (MP) for the efficacy and safety of primary Sjögren's syndrome (pSS) by a meta-analysis...
10.
Li S, Duan W, Li B, Chen S, Lyu T, Wang X, et al.
Zhonghua Gan Zang Bing Za Zhi
. 2023 Aug;
31(7):705-709.
PMID: 37580252
To investigate the clinical features and long-term prognosis of primary biliary cholangitis (PBC) in patients with past hepatitis B virus (HBV) infection. 353 cases with PBC who visited the Liver...